•  Transparency

  • News

  •  Healthcare Professionals

  • Contact us


What You Need to Know About Gaucher Disease

Your Health / Conditions / Rare Diseases / What You Need to Know About Gaucher Disease​​​​​​​

Published on Nov 22, 2017​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​
​​​​​​​Medically reviewed by Sukirti Bagal, MD, MPH


Q: What is Gaucher disease?

A: Gaucher disease is a rare, inherited disease. It was first described by Dr. Philippe Gaucher in 1882 and is caused by genetic mutations (a permanent change in the DNA of a gene)  received from both parents. In people with Gaucher disease, the body’s cells do not produce enough of an enzyme called glucocerebrosidase (pronounced “GLOO-ko-SERe-bro-sy-dase”). Without enough of this enzyme, people with Gaucher disease can’t break down a fatty substance found in cells known as glucocerebroside (pronounced “GLOO-ko-SER-e-bro-side”). This fatty substance builds up in some cells and enlarges them. These enlarged cells are called Gaucher cells.

Over time, Gaucher cells collect in some organs including the liver, spleen, lungs, and bone marrow, damaging them until they can’t work the way they should. The bone-related damage can be especially painful and may eventually limit a person’s mobility. In rare cases, Gaucher cells can also collect in the brain and result in a more severe form of the disease.

Q: Who gets Gaucher disease and how do they get it?

    A: Gaucher disease is an inherited condition, meaning it’s passed down from one generation to the next through the genes of one’s parents. As with all of our traits, we inherit a pair of genes (one gene from each parent) that is responsible for our ability to produce glucocerebrosidase. A person gets Gaucher disease when the mother and father each carry an abnormal copy of this gene and the child receives an abnormal copy from both parents. If a person inherits only one of these abnormal genes, they are considered a carrier. That means they do not have the disease but can pass the gene on to their children.

    Gaucher disease can affect people of any ethnicity, but it is more common in people of Ashkenazi Jewish background.

                  Q: How rare is Gaucher disease?

                  A: About 1 in 57,000 people have Gaucher disease or approximately 130,000 people worldwide. About 1 in 855 people of Ashkenazi Jewish descent have Gaucher disease.

                  Q: What are the signs and symptoms of Gaucher disease?

                  A: The signs and symptoms of Gaucher disease vary from one person to another. Some people have very mild symptoms and live with them for years before being diagnosed with the disease. Others have more severe symptoms.

                  Common signs and symptoms include:

                  • Low haemoglobin (anaemia)
                  • Low platelet count
                  • Enlarged liver
                  • Enlarged spleen
                  • Bone pain
                  • Bone disease
                  • Fatigue
                  • Easy bruising

                  Less common signs and symptoms include:

                  • Heart and lung problems
                  • Cognitive impairment
                  • Seizure
                  • Dementia

                  Q: What are the different types of Gaucher disease?

                  A: There are three different types of Gaucher disease.

                  Type 1 Gaucher disease is the most common and accounts for more than 90% of cases. The signs and symptoms of type 1 can begin at any age and they usually include anaemia bruising, bleeding, abdominal pain (caused by an increase in spleen and liver size), bone pain and growth problems. People with type 1 Gaucher disease can often expect to have a nomal life span. Type 1 is also sometimes called the adult form of Gaucher disease, although the cause is present from the time of conception. Type 1 Gaucher disease occurs worldwide in all populations, but is most prevalent in the Ashkenazi Jewish population.

                  Type 2 Gaucher disease is characterized by abnormalities of the central nervous system and is usually fatal during the first two to four years of life. Type 2 Gaucher disease equally affects people worldwide but is very rare.

                  Type 3 Gaucher disease is also very rare and equally common among ethnic populations. In this type of Gaucher disease, the neurologic symptoms progress slowly. Symptoms usually develop in childhood and continue through adulthood.​​​​​​​

                  Treatment can help with some of the symptoms of the disease, especially for people who receive a diagnosis and begin treatment early.

                  Q: How is Gaucher disease diagnosed?

                  A: The most common symptoms of Gaucher disease may cause a doctor to suspect the condition, but these symptoms cannot be used on their own as a way to diagnose the disease. Instead, a diagnosis of Gaucher disease can be made with a blood test. The test will measure glucosylceramidase enzyme activity in the blood.

                  For people with a known family history of Gaucher disease, a diagnosis can be confirmed with genetic testing. Carrier testing can also be done for individuals who have a family history. If the child’s mother and father are both carriers, there is a 25% chance that the child will be affected by Gaucher disease and a 50% chance that the child will be a carrier.

                  Genetic counselling is recommended for prospective parents with a family history of Gaucher disease, and prenatal testing can also be done to learn if a foetus in the womb has Gaucher disease.

                  Q: Can Gaucher disease be treated?

                  A: Although there is currently no cure for Gaucher disease, treatment can help people manage some of the symptoms of the disease. Enzyme replacement therapy can be used in most people with types 1 and 3 Gaucher disease. There are no effective treatments for those with types 2 and 3 Gaucher disease and severe brain involvement. It is best to discuss treatment options with a treating physician.

                  Q. Where can people with Gaucher disease and their family members find support for coping with the condition?

                  See links under Take the Next Step.


                  1. Mielke PJ, et al. Prevalence of lysomal storage disorders. JAMA 1999; 281(3):249-254. Accessed 14/2/2017.
                  2. National Organization for Rare Diseases. Accessed 14/2/2017.

                  Last reviewed: 16/09/2020


                  External Resources

                  -Genetic Alliance Australia - Gaucher Disease
                  -Brain Foundation Australia - Gaucher Disease
                  -National Gaucher Foundation
                  -National Organization for Rare Disorders (NORD)
                  -Genetic and Rare Disease Information Center (GARD)

                  Your HealthConditionsManaging your healthABOUT US About Pfizer Australia  Our history Our locations  Manufacturing OUR SCIENCE Our focus areas Search for a Clinical Trial Clinical Research Supporting Australian Scientists Centre for Therapeutic Innovation Pfizer Healthcare Hub Pfizer Medical Information OUR PRODUCTS Product finderMedical Information Contacts OUR PEOPLE Careers Leadership team Pfizer Australia CSR program Reconciliation@PfizerOur values